000 | 01828 a2200505 4500 | ||
---|---|---|---|
005 | 20250517154357.0 | ||
264 | 0 | _c20180822 | |
008 | 201808s 0 0 eng d | ||
022 | _a1523-1747 | ||
024 | 7 |
_a10.1016/j.jid.2016.12.029 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWalker, Joanna L | |
245 | 0 | 0 |
_a5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial. _h[electronic resource] |
260 |
_bThe Journal of investigative dermatology _c06 2017 |
||
300 |
_a1367-1370 p. _bdigital |
||
500 | _aPublication Type: Letter; Multicenter Study; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aFacial Dermatoses _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKeratosis, Actinic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPrecancerous Conditions _xdrug therapy |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSiegel, Julia A | |
700 | 1 | _aSachar, Moniyka | |
700 | 1 | _aPomerantz, Hyemin | |
700 | 1 | _aChen, Suephy C | |
700 | 1 | _aSwetter, Susan M | |
700 | 1 | _aDellavalle, Robert P | |
700 | 1 | _aStricklin, George P | |
700 | 1 | _aQureshi, Abrar A | |
700 | 1 | _aDiGiovanna, John J | |
700 | 1 | _aWeinstock, Martin A | |
773 | 0 |
_tThe Journal of investigative dermatology _gvol. 137 _gno. 6 _gp. 1367-1370 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jid.2016.12.029 _zAvailable from publisher's website |
999 |
_c27199007 _d27199007 |